Tissue Regenix Group PLC (FRA:LSW)
€ 0.675 -0.01 (-1.46%) Market Cap: 48.93 Mil Enterprise Value: 54.99 Mil PE Ratio: 0 PB Ratio: 1.80 GF Score: 43/100

Half Year 2023 Tissue Regenix Group PLC Earnings Call Transcript

Sep 05, 2023 / 03:30PM GMT
Release Date Price: €0.655 (+18.02%)
Operator

Good afternoon, ladies and gentlemen. Welcome to the Tissue Regenix Group plc interim results investor presentation. (Operator Instructions) Before we begin, we'd like to submit the following poll if you could give that your kind attention, I'm sure the company would be most grateful. It's been great pleasure to hand over to CEO, Daniel Lee. Good afternoon.

Daniel Lee
Tissue Regenix Group plc - CEO

Good afternoon, everyone. Thank you for joining us and spending some time with us as we would like to share with you an update on Tissue Regenix and our performance during the first half of 2023. Again, we'll talk about our activities, some of the successful results, and our plans to -- our continuing plans for the future. Disclaimer slide, that should be reviewed by all.

And then, your presenters today are myself, I'm Daniel Lee, I'm the Chief Executive Officer for Tissue Regenix. I was appointed CEO in November of 2020, but I originally joined the organization as the President of US Operations in January 2019 of the CellRight division, which was an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot